batch s820002 (Toronto Research Chemicals)
Toronto Research Chemicals is a verified supplier 
Toronto Research Chemicals manufactures this product 
86
Structured Review
Toronto Research Chemicals
batch s820002
Batch S820002, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sunitinib+d10/Sunitinib-d10+with+exact+weight+packaging/pm31784210-62-30-69
Average 86 stars, based on 1 article reviews
Batch S820002, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sunitinib+d10/Sunitinib-d10+with+exact+weight+packaging/pm31784210-62-30-69
Average 86 stars, based on 1 article reviews
batch s820002 - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
High Performance Liquid Chromatography:Article Title: Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry (LC/MS/MS): application to a pharmacokinetic study Article Snippet: .. 2.1 Chemicals and reagents Sunitinib Malate (Lot number 5-ANR-67-1, 73.0% pure by HPLC, free drug), N-desethyl sunitinib (Lot number 1-WHH-36-3, 98.0% pure by HPLC) and the deutrated internal standard, Article Title: Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry (LC/MS/MS): application to a pharmacokinetic study Article Snippet: .. Sunitinib Malate (Lot number 5-ANR-67-1, 73.0% pure by HPLC, free drug), N-desethyl sunitinib (Lot number 1-WHH-36-3, 98.0% pure by HPLC) and the deutrated internal standard, Article Title: Quantitation of unbound sunitinib and its metaboliteN-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study Article Snippet: .. Sunitinib malate (lot number 5-ANR-67-1, 73.0% pure by HPLC, free drug), N-desethyl sunitinib (lot number 1-WHH-36-3, 98.0% pure by HPLC) and the deutrated internal standard, Clinical Proteomics:Article Title: Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension Article Snippet: Jo Background: Tyrosine kinase inhibitors targeting angiogenesis have become an important part of the treatment of patients with several types of cancer.. One of the most reported side effects of vascular endothelial growth factor receptor (VEGFR)-targeted therapies is hypertension.. In this study, we hypothesized that the development of hypertension in patients treated with sunitinib, a multitargeted tyrosine kinase inhibitor, is preceded by reduced endothelium-dependent vasodilation. |